Litman Gregory Asset Management »

Pacira Pharmaceuticals shares owned by Litman Gregory Asset Management

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Litman Gregory Asset Management from 13F filings

Historical chart of Litman Gregory Asset Management investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Litman Gregory Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Litman Gregory Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $19k 750 25.88

More positions owned by Litman Gregory Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Core Msci Emkt (IEMG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Mid Cap Etf (VO)
Litman Gregory Fds Tr Imgp Dbi Managed (DBMF)
Apple (AAPL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Litman Gregory Asset Management

Top funds holding Pacira Pharmaceuticals

BlackRock
Vanguard Group
Doma Perpetual Capital Management
D. E. Shaw & Co
Dimensional Fund Advisors
Renaissance Technologies
State Street Corporation
American Century Companies
Goldman Sachs Group
Geode Capital Management
Balyasny Asset Management
Citadel Advisors
Impax Asset Management Group
Charles Schwab Investment Management
UBS Group

View all funds holding Pacira Pharmaceuticals